Replies to post #3840 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

“Option creep” is not a matter of great consequence for MNTA investors in the overall scheme of things.

In any case, the discussion of Palo Alto’s request is academic; I guarantee that MNTA has no intention of buying back shares.